cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AA789296 | .e | 1 to 614 | 616 to 3 | M20I | tiling clone, | 614/616 (99 %) | 1 diff (99.9 %id) | ||
AA305210 | colon | .g | 16 to 513 | 1 to 493 | A33R S34P F35S F36S P37R ... | 493/493 (100 %) | 6 diff (98.8 %id) | ||
AB244718 | .a | 787 to 2421 | 1 to 1635 | exact | 1635/1635 (100 %) | 0 diff (100 %id) | |||
AJ420584 | .a | 1411 to 2992 | 9 to 1589 | tiling clone, AAA | 1581/1897 (83 %) | 8 diff (99.6 %id) | |||
AK000488 | .a | 680 to 2560 | 1 to 1882 | V45G Q46A Q47A T48D Q49A ... | available from FLJ, AAA | Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) | 1882/1882 (100 %) | 2 diff (99.9 %id) | |
AK023271 | .a | 2481 to 4506 | 1 to 2026 | available from FLJ, | 2026/2026 (100 %) | 5 diff (99.8 %id) | |||
AK126523 | uterus | .j-u | 1 to 3829 | 2 to 3826 | K39R E40K N41P P42T H43L ... | tiling clone, available from FLJ, | 3826/3826 (100 %) | 5 diff (99.9 %id) | |
AK308386 | trachea | .a | 677 to 2773 | 1 to 2095 | L111* | 2095/2095 (100 %) | 4 diff (99.9 %id) | ||
DA021641 | .a | 2245 to 2820 | 2 to 578 | capped | 577/577 (100 %) | 3 diff (99.5 %id) | |||
DA021662 | .a | 2245 to 2819 | 2 to 576 | capped | 575/575 (100 %) | 2 diff (99.7 %id) | |||
AW366682 | head_neck | .a | 5023 to 5649 | 625 to 1 | tiling clone, | 625/630 (99 %) | 12 diff (98.1 %id) | ||
AW966647 | .a | 5438 to 5986 | 552 to 1 | Submitted on the opposite strand | 552/554 (99 %) | 11 diff (98.1 %id) | |||
AY052551 | .d-u | 30 to 1011 | 1 to 982 | E74Q | 982/982 (100 %) | 2 diff (99.8 %id) | |||
Z28884 | leg muscle, skeletal muscle | .k-u | 1 to 265 | 1 to 265 | F11X | tiling clone, | 265/265 (100 %) | 2 diff (99.3 %id) | |
AU185614 | skin | .j-u | 74 to 481 | 1 to 408 | 408/408 (100 %) | 1 diff (99.8 %id) | |||
BC002472 | Kidney, renal cell adenocarcinoma | .a | 647 to 2560 | 1 to 1914 | exact | tiling clone, available from MGC, AAA | Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) | 1914/1914 (100 %) | 1 diff (100.0 %id) |
BC005397 | Bladder, carcinoma | .d-u | 14 to 1012 | 1 to 999 | exact | tiling clone, available from MGC, AAA | Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) | 999/999 (100 %) | 0 diff (100 %id) |
BC006000 | Bladder, carcinoma | .d-u | 2 to 1010 | 1 to 1009 | exact | available from MGC, AAA | Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) | 1009/1010 (99 %) | 1 diff (100.0 %id) |
BE168962 | head_neck | .a | 3255 to 3538 | 8 to 291 | 284/299 (94 %) | 6 diff (98.0 %id) | |||
BE828861 | lung_tumor | .a | 5189 to 5597 | 24 to 429 | 406/435 (93 %) | 13 diff (97.1 %id) | |||
BF093592 | testis_normal | .a | 5442 to 5602 | 178 to 19 | 160/192 (83 %) | 0 diff (100 %id) | |||
BF335544 | colon | .a | 1374 to 1846 | 10 to 489 | 480/509 (94 %) | 37 diff (92.8 %id) | |||
BF904317 | marrow | .a | 1719 to 2001 | 1 to 283 | 283/300 (94 %) | 18 diff (94.0 %id) | |||
BF904318 | marrow | .a | 1608 to 2001 | 403 to 9 | Submitted on the opposite strand | 395/405 (97 %) | 12 diff (97.1 %id) | ||
BG948983 | bocio_tumor | .b | 1 to 564 | 8 to 572 | tiling clone, | 565/572 (98 %) | 9 diff (98.5 %id) | ||
BG998341 | head_neck | .a | 3999 to 4656 | 9 to 661 | 653/663 (98 %) | 18 diff (97.3 %id) | |||
BI028298 | marrow | .a | 2384 to 2775 | 1 to 393 | 393/393 (100 %) | 4 diff (99.0 %id) | |||
BQ361076 | ovary | .a | 2676 to 2935 | 19 to 279 | 261/283 (92 %) | 9 diff (96.9 %id) | |||
BQ361078 | ovary | .a | 2676 to 2935 | 19 to 279 | 261/283 (92 %) | 9 diff (96.9 %id) | |||
DA104302 | cerebellum | .a | 729 to 1284 | 2 to 557 | capped | 556/556 (100 %) | 2 diff (99.7 %id) | ||
DA114123 | cerebellum | .a | 729 to 1300 | 2 to 573 | capped | 572/572 (100 %) | 2 diff (99.7 %id) | ||
DA145862 | amygdala | .g | 3 to 574 | 2 to 573 | exact | tiling clone, capped | 572/572 (100 %) | 1 diff (99.9 %id) | |
DA218811 | brain | .a | 729 to 1356 | 2 to 630 | capped | 629/629 (100 %) | 3 diff (99.6 %id) | ||
DA227325 | brain | .a | 729 to 1299 | 2 to 572 | capped | 571/571 (100 %) | 2 diff (99.7 %id) | ||
DA232933 | brain | .a | 678 to 1234 | 2 to 558 | capped | 557/557 (100 %) | 0 diff (100 %id) | ||
DA236437 | brain | .a | 868 to 1441 | 2 to 575 | capped | 574/574 (100 %) | 1 diff (99.9 %id) | ||
DA237332 | brain | .a | 727 to 1263 | 2 to 539 | capped | 538/538 (100 %) | 3 diff (99.5 %id) | ||
DA334258 | hippocampus | .a | 653 to 1210 | 2 to 559 | capped | 558/558 (100 %) | 2 diff (99.7 %id) | ||
BX090699 | whole brain | .a | 5500 to 5989 | 503 to 13 | 491/503 (97 %) | 0 diff (100 %id) | |||
BX106619 | placenta | .a | 2085 to 2565 | 481 to 2 | Submitted on the opposite strand | 480/481 (99 %) | 0 diff (100 %id) | ||
BX118074 | heart | .d-u | 31 to 669 | 1 to 639 | 639/639 (100 %) | 0 diff (100 %id) | |||
BX641069 | human fetal kidney | .c | 65 to 5347 | 1 to 5284 | N27K D28* | tiling clone, available from DKFZ, AAA | Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) | 5284/5284 (100 %) | 6 diff (99.9 %id) |
Z41616 | brain, total brain | .a | 5725 to 5987 | 263 to 1 | 263/263 (100 %) | 2 diff (99.3 %id) | |||
CN277293 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 3251 to 3767 | 1 to 517 | 517/517 (100 %) | 0 diff (100 %id) | |||
CN286009 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 4161 to 4526 | 62 to 426 | 365/438 (83 %) | 4 diff (99.1 %id) | |||
CN292757 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 5659 to 5987 | 1 to 331 | 331/331 (100 %) | 4 diff (98.8 %id) | |||
CN350665 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 1035 to 1249 | 1 to 215 | 215/215 (100 %) | 0 diff (100 %id) | |||
CN350666 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 936 to 1663 | 1 to 728 | 728/728 (100 %) | 1 diff (99.9 %id) | |||
CN388373 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 2184 to 2908 | 1 to 726 | 726/726 (100 %) | 3 diff (99.6 %id) | |||
CN388374 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .f | 28 to 766 | 1 to 739 | exact | tiling clone, | 739/739 (100 %) | 2 diff (99.8 %id) | |
CN388375 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .i | 1 to 481 | 530 to 50 | exact | tiling clone, AAA | Submitted on the opposite strand | 481/481 (100 %) | 1 diff (99.8 %id) |
CU452623 | epidermis | .e | 71 to 536 | 1 to 467 | 467/474 (98 %) | 12 diff (97.5 %id) | |||
CV025535 | mixed | .a | 787 to 1352 | 1 to 566 | 566/566 (100 %) | 0 diff (100 %id) | |||
CV422315 | marrow | .a | 1723 to 2001 | 1 to 284 | 284/301 (94 %) | 32 diff (89.4 %id) | |||
AL601202 | .a | 2642 to 2998 | 1 to 357 | 357/357 (100 %) | 0 diff (100 %id) | ||||
BX473972 | .a | 1146 to 1685 | 1 to 540 | 540/540 (100 %) | 1 diff (99.9 %id) | ||||
BX477165 | .h | 1 to 427 | 1 to 427 | exact | tiling clone, | 427/427 (100 %) | 6 diff (98.6 %id) | ||
EL733350 | mixed | .d-u | 87 to 660 | 1 to 574 | 574/574 (100 %) | 0 diff (100 %id) | |||
FN051737 | breast carcinoma | .a | 5740 to 5817 | 79 to 1 | Submitted on the opposite strand | 79/80 (98 %) | 1 diff (98.8 %id) | ||
FN138957 | breast carcinoma | .a | 5284 to 5398 | 1 to 116 | 116/121 (95 %) | 3 diff (97.6 %id) | |||
FN163992 | breast carcinoma | .a | 4241 to 4322 | 1 to 81 | 81/81 (100 %) | 2 diff (97.6 %id) | |||
FN165617 | breast carcinoma | .a | 5714 to 5830 | 4 to 118 | 115/118 (97 %) | 6 diff (95.0 %id) | |||
GD143355 | .j-u | 388 to 481 | 1 to 94 | AAA | Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) | 94/94 (100 %) | 2 diff (97.9 %id) | ||
GD152910 | .e | 352 to 613 | 1 to 262 | AAA | Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) | 262/262 (100 %) | 7 diff (97.4 %id) | ||
GD154029 | .j-u | 392 to 481 | 6 to 94 | AAA | Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) | 89/94 (94 %) | 6 diff (93.7 %id) | ||
D62523 | .a | 4111 to 4423 | 1 to 312 | 312/312 (100 %) | 1 diff (99.7 %id) | ||||
D62701 | .a | 4110 to 4325 | 21 to 236 | 216/236 (91 %) | 6 diff (97.5 %id) | ||||
DB533371 | hippocampus | .a | 5572 to 5985 | 1 to 420 | Submitted on the opposite strand | 420/420 (100 %) | 9 diff (97.9 %id) | ||
DB539508 | hippocampus | .a | 3487 to 3935 | 1 to 449 | Submitted on the opposite strand | 449/449 (100 %) | 8 diff (98.3 %id) | ||
DB473062 | hippocampus | .a | 691 to 1159 | 1 to 469 | 469/469 (100 %) | 0 diff (100 %id) | |||
DB541817 | hippocampus | .a | 3462 to 3935 | 1 to 475 | Submitted on the opposite strand | 475/475 (100 %) | 4 diff (99.2 %id) | ||
DB563473 | hypothalamus | .j-u | 66 to 481 | 1 to 416 | Submitted on the opposite strand | 416/416 (100 %) | 9 diff (97.9 %id) | ||
DB497244 | hypothalamus | .a | 677 to 1168 | 1 to 492 | 492/492 (100 %) | 1 diff (99.8 %id) | |||
DB568294 | hypothalamus | .a | 4059 to 4526 | 1 to 464 | Submitted on the opposite strand | 464/464 (100 %) | 2 diff (99.6 %id) | ||
BP234732 | coronary artery | .a | 677 to 1258 | 1 to 582 | 582/582 (100 %) | 2 diff (99.7 %id) | |||
DA579251 | .a | 713 to 1265 | 2 to 554 | capped | 553/553 (100 %) | 0 diff (100 %id) | |||
AV721622 | hypothalamus | .a | 4869 to 5583 | 1 to 711 | 711/723 (98 %) | 25 diff (96.6 %id) | |||
R37962 | whole brain | .a | 5717 to 5984 | 284 to 13 | 272/284 (95 %) | 0 diff (100 %id) | |||
R38885 | whole brain | .a | 5666 to 5989 | 332 to 7 | 326/333 (97 %) | 0 diff (100 %id) | |||
T81274 | whole brain | .a | 4893 to 5347 | 1 to 474 | 474/481 (98 %) | 26 diff (94.6 %id) | |||
R13140 | whole brain | .a | 4930 to 5254 | 1 to 340 | 340/344 (98 %) | 22 diff (93.7 %id) | |||
R40621 | whole brain | .a | 5592 to 5989 | 407 to 7 | 401/407 (98 %) | 0 diff (100 %id) | |||
R46147 | whole brain | .a | 5692 to 5989 | 307 to 7 | 301/307 (98 %) | 0 diff (100 %id) | |||
R35259 | whole brain | .a | 3087 to 3598 | 1 to 513 | Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) | 513/513 (100 %) | 10 diff (98.1 %id) | ||
R50930 | whole brain | .a | 4123 to 4526 | 424 to 14 | AAA | Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) | 411/417 (98 %) | 14 diff (96.7 %id) | |
H28930 | whole brain | .a | 4868 to 5280 | 1 to 415 | tiling clone, | 415/512 (81 %) | 7 diff (98.7 %id) | ||
H28931 | whole brain | .a | 5520 to 5989 | 477 to 7 | 471/485 (97 %) | 0 diff (100 %id) | |||
R21432 | placenta | .a | 3795 to 4154 | 1 to 377 | 377/391 (96 %) | 17 diff (95.7 %id) | |||
R79634 | placenta | .a | 2325 to 2535 | 215 to 1 | Submitted on the opposite strand | 215/224 (95 %) | 19 diff (91.6 %id) | ||
N32611 | placenta | .a | 895 to 1363 | 1 to 471 | Submitted on the opposite strand | 471/481 (97 %) | 8 diff (98.4 %id) | ||
N70822 | lung | .a | 5715 to 5992 | 278 to 1 | 278/278 (100 %) | 0 diff (100 %id) | |||
W01456 | lung | .a | 4873 to 5299 | 1 to 437 | 437/449 (97 %) | 15 diff (96.7 %id) | |||
W20468 | heart | .d-u | 639 to 1012 | 375 to 1 | 375/375 (100 %) | 2 diff (99.5 %id) | |||
W32720 | heart | .d-u | 30 to 231 | 1 to 202 | 202/202 (100 %) | 1 diff (99.6 %id) | |||
AA757628 | pineal gland | .a | 895 to 1257 | 1 to 362 | Submitted on the opposite strand | 362/362 (100 %) | 9 diff (97.6 %id) | ||
AA234722 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .b | 961 to 1391 | 427 to 1 | fully sequenced, | 427/427 (100 %) | 8 diff (98.2 %id) | ||
AA234789 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .b | 597 to 991 | 1 to 394 | fully sequenced, | 394/394 (100 %) | 1 diff (99.8 %id) | ||
AA450333 | .a | 3435 to 3729 | 1 to 295 | Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) | 295/295 (100 %) | 0 diff (100 %id) | |||
AA450334 | .a | 4205 to 4506 | 311 to 14 | AAA | Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) | 298/298 (100 %) | 2 diff (99.4 %id) | ||
AA668427 | .a | 2344 to 2560 | 217 to 1 | 217/217 (100 %) | 4 diff (98.2 %id) | ||||
AA229269 | .e | 376 to 617 | 246 to 5 | tiling clone, | 242/246 (98 %) | 0 diff (100 %id) | |||
AA583618 | larynx | .b | 1000 to 1391 | 391 to 1 | tiling clone, | 391/391 (100 %) | 2 diff (99.5 %id) | ||
AA602968 | .a | 5117 to 5443 | 429 to 103 | 327/429 (76 %) | 0 diff (100 %id) | ||||
AA854575 | parathyroid gland, parathyroid tumor | .a | 893 to 1331 | 1 to 439 | Submitted on the opposite strand | 439/439 (100 %) | 3 diff (99.4 %id) | ||
AA834403 | adenocarcinoma, colon | .a | 895 to 1255 | 1 to 360 | 360/360 (100 %) | 5 diff (98.7 %id) | |||
AI073885 | pooled | .a | 895 to 1348 | 1 to 454 | Submitted on the opposite strand | 454/454 (100 %) | 0 diff (100 %id) | ||
AA962811 | 2 pooled tumors (clear cell type), Kidney | .a | 895 to 1244 | 1 to 348 | Submitted on the opposite strand | 348/348 (100 %) | 5 diff (98.6 %id) | ||
AA961638 | pooled | .a | 403 to 841 | 439 to 1 | 439/439 (100 %) | 8 diff (98.2 %id) | |||
AI023087 | parathyroid gland, parathyroid tumor | .a | 2153 to 2560 | 418 to 11 | AAA | Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) | 408/408 (100 %) | 2 diff (99.6 %id) | |
AI039519 | .a | 5676 to 5873 | 381 to 184 | 198/381 (51 %) | 0 diff (100 %id) | ||||
AI076872 | brain, glioblastoma (pooled) | .a | 4062 to 4506 | 441 to 1 | 441/441 (100 %) | 2 diff (99.6 %id) | |||
AI189011 | placenta | .a | 4034 to 4506 | 468 to 1 | 468/468 (100 %) | 3 diff (99.4 %id) | |||
AI302534 | 2 pooled tumors (clear cell type), Kidney | .a | 2172 to 2559 | 393 to 7 | 387/393 (98 %) | 0 diff (100 %id) | |||
AI310758 | 2 pooled tumors (clear cell type), Kidney | .a | 5536 to 5989 | 461 to 8 | 454/461 (98 %) | 0 diff (100 %id) | |||
AI493045 | Kidney | .a | 5608 to 5987 | 380 to 1 | 380/380 (100 %) | 1 diff (99.8 %id) | |||
AI335240 | 2 pooled tumors (clear cell type), Kidney | .a | 5398 to 5989 | 593 to 3 | 591/593 (99 %) | 0 diff (100 %id) | |||
AI420081 | Prostate | .e | 214 to 614 | 400 to 1 | 400/401 (99 %) | 1 diff (99.8 %id) | |||
AI393473 | pooled | .a | 2152 to 2560 | 419 to 11 | AAA | Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) | 409/409 (100 %) | 1 diff (99.8 %id) | |
AI521762 | Kidney | .a | 2204 to 2560 | 357 to 1 | 357/357 (100 %) | 1 diff (99.8 %id) | |||
AI470627 | Kidney | .a | 2258 to 2560 | 304 to 1 | 304/304 (100 %) | 4 diff (98.7 %id) | |||
AI453003 | pooled | .j-u | 4 to 486 | 483 to 1 | 483/483 (100 %) | 3 diff (99.4 %id) | |||
AI580368 | Kidney | .a | 876 to 1261 | 1 to 386 | Submitted on the opposite strand | 386/386 (100 %) | 0 diff (100 %id) | ||
AI499523 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .a | 4073 to 4493 | 417 to 1 | 417/417 (100 %) | 2 diff (99.6 %id) | |||
AI913194 | adenocarcinoma, Pancreas | .a | 3515 to 3934 | 434 to 15 | AAA | Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) | 420/420 (100 %) | 4 diff (99.1 %id) | |
AI741672 | pooled | .a | 895 to 1297 | 1 to 403 | Submitted on the opposite strand | 403/403 (100 %) | 0 diff (100 %id) | ||
AI760063 | pooled | .e | 124 to 617 | 497 to 1 | 497/497 (100 %) | 21 diff (95.8 %id) | |||
AI915099 | colon, colon tumor, RER+ | .a | 5548 to 5993 | 457 to 8 | 450/457 (98 %) | 0 diff (100 %id) | |||
AI765437 | 2 pooled tumors (clear cell type), Kidney | .a | 5398 to 5989 | 595 to 4 | tiling clone, | 592/596 (99 %) | 0 diff (100 %id) | ||
AI767972 | 2 pooled tumors (clear cell type), Kidney | .a | 5630 to 5989 | 365 to 6 | tiling clone, | 360/365 (98 %) | 0 diff (100 %id) | ||
AI769572 | 2 pooled tumors (clear cell type), Kidney | .a | 895 to 1336 | 1 to 443 | Submitted on the opposite strand | 443/443 (100 %) | 2 diff (99.6 %id) | ||
AI824107 | lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) | .b | 801 to 1389 | 589 to 1 | 589/589 (100 %) | 1 diff (99.9 %id) | |||
AI830042 | lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) | .a | 876 to 1312 | 1 to 437 | Submitted on the opposite strand | 437/437 (100 %) | 4 diff (99.1 %id) | ||
AI866729 | adenocarcinoma, Pancreas | .a | 4071 to 4492 | 422 to 1 | 422/422 (100 %) | 1 diff (99.8 %id) | |||
AI923528 | lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) | .a | 895 to 1424 | 1 to 530 | Submitted on the opposite strand | 530/530 (100 %) | 1 diff (99.9 %id) | ||
AW241581 | pooled germ cell tumors | .a | 5511 to 5987 | 477 to 1 | 477/477 (100 %) | 1 diff (99.8 %id) | |||
AW237679 | Kidney | .a | 5558 to 5986 | 430 to 1 | 430/430 (100 %) | 1 diff (99.8 %id) | |||
AW241940 | pooled | .a | 293 to 841 | 549 to 1 | 549/549 (100 %) | 1 diff (99.9 %id) | |||
AW015627 | .a | 859 to 1237 | 1 to 379 | Submitted on the opposite strand | 379/379 (100 %) | 0 diff (100 %id) | |||
AW205091 | .a | 5577 to 5987 | 429 to 18 | AAA | Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) | 412/412 (100 %) | 1 diff (99.8 %id) | ||
AW264795 | lung, two pooled squamous cell carcinomas | .a | 5566 to 5989 | 425 to 1 | 425/425 (100 %) | 1 diff (99.8 %id) | |||
AW472912 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .i | 87 to 488 | 406 to 5 | tiling clone, | 402/406 (99 %) | 0 diff (100 %id) | ||
AW269515 | lung, two pooled squamous cell carcinomas | .a | 3979 to 4513 | 532 to 2 | 531/532 (99 %) | 0 diff (100 %id) | |||
AW518379 | lymph node, lymphoma, follicular mixed small and largecell | .a | 4352 to 4623 | 287 to 12 | AAA | Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) | 276/278 (99 %) | 9 diff (96.8 %id) | |
AW470817 | 2 pooled tumors (clear cell type), Kidney | .a | 5513 to 5989 | 485 to 8 | 478/485 (98 %) | 0 diff (100 %id) | |||
AW629253 | pooled | .a | 339 to 840 | 503 to 2 | 502/503 (99 %) | 0 diff (100 %id) | |||
BM986825 | mixed | .d-u | 26 to 508 | 6 to 489 | Submitted on the opposite strand | 484/489 (98 %) | 6 diff (98.8 %id) | ||
AW872882 | squamous cell carcinoma, tongue | .a | 3472 to 3934 | 472 to 10 | 463/472 (98 %) | 0 diff (100 %id) | |||
BE327017 | Kidney | .a | 5541 to 5987 | 460 to 14 | AAA | Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) | 447/447 (100 %) | 1 diff (99.8 %id) | |
BE465211 | Kidney | .a | 719 to 864 | 146 to 1 | 146/146 (100 %) | 1 diff (99.4 %id) | |||
BF438871 | pooled | .j-u | 74 to 486 | 413 to 1 | 413/413 (100 %) | 0 diff (100 %id) | |||
BE272563 | Kidney, renal cell adenocarcinoma | .a | 666 to 1267 | 1 to 603 | 603/604 (99 %) | 3 diff (99.6 %id) | |||
BE272481 | Kidney, renal cell adenocarcinoma | .a | 666 to 1198 | 1 to 533 | 533/533 (100 %) | 0 diff (100 %id) | |||
BF593463 | Kidney | .g | 220 to 572 | 1 to 353 | Submitted on the opposite strand | 353/353 (100 %) | 0 diff (100 %id) | ||
BE568411 | bladder, carcinoma, cell line | .a | 3567 to 4246 | 1 to 660 | 660/875 (75 %) | 34 diff (96.2 %id) | |||
BE564219 | bladder, carcinoma, cell line | .d-u | 32 to 811 | 1 to 759 | 759/767 (98 %) | 30 diff (96.1 %id) | |||
BE564922 | bladder, carcinoma, cell line | .b | 420 to 1081 | 1 to 666 | 666/905 (73 %) | 29 diff (96.8 %id) | |||
BE565002 | bladder, carcinoma, cell line | .b | 411 to 1089 | 1 to 682 | 682/807 (84 %) | 42 diff (94.8 %id) | |||
BE867922 | adenocarcinoma, colon | .a | 2144 to 2886 | 1 to 729 | 729/869 (83 %) | 26 diff (97.1 %id) | |||
BE869617 | adenocarcinoma, colon | .a | 2702 to 3435 | 19 to 722 | 704/876 (80 %) | 15 diff (98.3 %id) | |||
BF028671 | bladder, carcinoma, cell line | .b | 455 to 1159 | 1 to 689 | 689/860 (80 %) | 42 diff (95.2 %id) | |||
BF246220 | brain, glioblastoma | .a | 3366 to 4106 | 1 to 739 | 739/840 (87 %) | 48 diff (94.3 %id) | |||
BF208515 | bladder, carcinoma, cell line | .d-u | 1 to 695 | 1 to 681 | tiling clone, | 681/897 (75 %) | 44 diff (95.1 %id) | ||
BF208824 | bladder, carcinoma, cell line | .b | 392 to 1005 | 1 to 608 | 608/697 (87 %) | 51 diff (92.7 %id) | |||
BF242280 | bone marrow, from acute myelogenous leukemia | .f | 1 to 484 | 1 to 492 | tiling clone, | 492/1176 (41 %) | 28 diff (97.7 %id) | ||
BC005981 | Bone marrow, acute myelogenous leukemia | .a | 2870 to 4526 | 1 to 1657 | tiling clone, available from MGC, AAA | Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) | 1657/1657 (100 %) | 1 diff (100.0 %id) | |
BF241908 | bone marrow, from acute myelogenous leukemia | .a | 2870 to 3453 | 1 to 586 | available from MGC, | 586/758 (77 %) | 22 diff (97.1 %id) | ||
BF667084 | brain, primitive neuroectoderm | .a | 3255 to 3925 | 29 to 685 | 657/863 (76 %) | 31 diff (96.5 %id) | |||
BF697597 | brain, primitive neuroectoderm | .a | 3905 to 3952 | 643 to 690 | 651/818 (79 %) | 22 diff (97.4 %id) | |||
BF679359 | Prostate | .a | 3329 to 3937 | 1 to 596 | 596/873 (68 %) | 26 diff (97.1 %id) | |||
BG180419 | adenocarcinoma, cell line, Prostate | .a | 4736 to 5437 | 1 to 691 | tiling clone, | 691/927 (74 %) | 22 diff (97.7 %id) | ||
BG287329 | bladder, transitional cell papilloma, cell line | .d-u | 43 to 809 | 1 to 770 | 770/954 (80 %) | 15 diff (98.5 %id) | |||
BG324612 | Kidney, renal cell adenocarcinoma | .a | 646 to 1392 | 1 to 744 | 744/856 (86 %) | 15 diff (98.3 %id) | |||
BG324903 | Kidney, renal cell adenocarcinoma | .a | 646 to 1252 | 1 to 605 | 605/605 (100 %) | 2 diff (99.7 %id) | |||
BG494918 | lung, mucoepidermoid carcinoma | .a | 3396 to 4097 | 1 to 700 | 700/700 (100 %) | 5 diff (99.3 %id) | |||
BG679603 | skin, squamous cell carcinoma | .b | 410 to 1341 | 1 to 943 | 943/954 (98 %) | 40 diff (95.9 %id) | |||
BG696590 | skin | .d-u | 32 to 774 | 1 to 745 | 745/745 (100 %) | 10 diff (98.7 %id) | |||
BG721402 | testis | .a | 686 to 1425 | 1 to 746 | 746/859 (86 %) | 16 diff (98.2 %id) | |||
BG772279 | testis | .a | 598 to 1419 | 1 to 818 | 818/818 (100 %) | 16 diff (98.1 %id) | |||
BG830402 | epithelioid carcinoma cell line, Pancreas | .a | 870 to 1469 | 1 to 593 | 594/593 (100 %) | 13 diff (97.9 %id) | |||
BI560819 | testis | .g | 1 to 705 | 1 to 708 | T13Q V14C P15Q G16V A17P ... | tiling clone, | 708/837 (84 %) | 21 diff (97.5 %id) | |
BI667155 | brain, hypothalamus | .a | 672 to 1350 | 1 to 680 | 680/681 (99 %) | 15 diff (97.8 %id) | |||
BI668785 | brain, hypothalamus | .a | 672 to 1368 | 1 to 699 | 699/700 (99 %) | 15 diff (97.9 %id) | |||
BM018631 | astrocytoma grade IV, cell line, brain | .b | 426 to 1255 | 1 to 826 | 826/826 (100 %) | 29 diff (96.5 %id) | |||
BM020484 | astrocytoma grade IV, cell line, brain | .d-u | 48 to 772 | 1 to 725 | 725/725 (100 %) | 1 diff (99.9 %id) | |||
BM914030 | astrocytoma grade IV, cell line, brain | .b | 466 to 1031 | 1 to 567 | tiling clone, | 567/1273 (44 %) | 13 diff (99.0 %id) | ||
BM914235 | astrocytoma grade IV, cell line, brain | .b | 429 to 1386 | 1 to 968 | AAA | Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) | 968/972 (99 %) | 43 diff (95.6 %id) | |
BQ014864 | Chondrosarcoma, Left Pubic Bone | .a | 5343 to 5985 | 662 to 19 | AAA | Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) | 644/644 (100 %) | 2 diff (99.7 %id) | |
BQ016004 | lung, Metastatic Chondrosarcoma | .a | 3871 to 4506 | 650 to 19 | AAA | Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) | 632/632 (100 %) | 4 diff (99.4 %id) | |
BQ016015 | lung, Metastatic Chondrosarcoma | .a | 3849 to 4506 | 672 to 19 | AAA | Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) | 654/654 (100 %) | 4 diff (99.4 %id) | |
BQ017492 | lung, Metastatic Chondrosarcoma | .a | 5807 to 5987 | 197 to 17 | AAA | Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) | 181/181 (100 %) | 0 diff (100 %id) | |
BQ429910 | melanotic melanoma, skin | .a | 3387 to 4002 | 1 to 626 | 626/1019 (61 %) | 19 diff (98.2 %id) | |||
BQ217897 | epithelioid carcinoma, Pancreas | .a | 1686 to 2363 | 1 to 688 | 688/988 (69 %) | 15 diff (98.5 %id) | |||
BU195114 | melanotic melanoma, skin | .a | 4043 to 4935 | 1 to 900 | tiling clone, | 900/901 (99 %) | 20 diff (97.8 %id) | ||
BU145898 | dorsal root ganglia | .a | 3681 to 4412 | 33 to 767 | 735/879 (83 %) | 17 diff (98.1 %id) | |||
BQ720497 | sympathetic trunk | .a | 3535 to 4453 | 1 to 923 | 923/924 (99 %) | 16 diff (98.3 %id) | |||
BQ723410 | sympathetic trunk | .a | 3498 to 4411 | 42 to 954 | 913/956 (95 %) | 19 diff (98.1 %id) | |||
CX872309 | embryonic stem | .a | 3501 to 4291 | 1 to 791 | tiling clone, | 791/791 (100 %) | 0 diff (100 %id) | ||
CB984961 | Pooled-Glandular | .a | 3701 to 4279 | 1 to 586 | 586/987 (59 %) | 15 diff (98.5 %id) | |||
CB996608 | placenta, pre-eclamptic placenta | .a | 676 to 1158 | 25 to 513 | 489/1171 (41 %) | 16 diff (98.7 %id) | |||
TI_44349224 | .g | 5 to 705 | 90 to 793 | T13Q V14C P15Q G16V A17P ... | 704/922 (76 %) | 20 diff (97.9 %id) | |||
TI_44342838 | .a | 673 to 1350 | 77 to 755 | 679/756 (89 %) | 17 diff (97.8 %id) | ||||
TI_44345490 | .a | 673 to 1368 | 94 to 791 | 698/792 (88 %) | 17 diff (97.9 %id) | ||||
TI_59389296 | .b | 427 to 1255 | 103 to 927 | 825/825 (100 %) | 28 diff (96.7 %id) | ||||
TI_59391271 | .d-u | 49 to 772 | 102 to 825 | 724/724 (100 %) | 0 diff (100 %id) | ||||
BP277979 | .a | 726 to 1309 | 1 to 583 | 583/583 (100 %) | 3 diff (99.5 %id) | ||||
BY996493 | .a | 2925 to 3596 | 20 to 691 | 672/691 (97 %) | 6 diff (99.2 %id) | ||||
BY996936 | .a | 3494 to 4168 | 10 to 684 | 675/684 (98 %) | 6 diff (99.2 %id) | ||||
DA671270 | .a | 2492 to 3080 | 2 to 593 | capped | 592/592 (100 %) | 6 diff (99.0 %id) | |||
DA671469 | .a | 3871 to 4442 | 2 to 573 | capped | 572/572 (100 %) | 1 diff (99.9 %id) | |||
DA672669 | .a | 689 to 1285 | 2 to 598 | capped | 597/597 (100 %) | 3 diff (99.5 %id) | |||
NM_017839.4 | .a | 606 to 5998 | 1 to 5393 | exact | RefSeq, | 5393/5395 (99 %) | 5 diff (100.0 %id) | ||
NM_032330.1 | .d-u | 2 to 1011 | 1 to 1010 | exact | RefSeq, AAA | Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) | 1010/1010 (100 %) | 1 diff (100.0 %id) | |
AU132727 | .a | 2482 to 3230 | 2 to 746 | capped | 745/787 (94 %) | 11 diff (98.7 %id) | |||
AU154202 | .a | 3984 to 4506 | 523 to 1 | 523/523 (100 %) | 1 diff (99.9 %id) | ||||
DB374236 | placenta | .a | 5520 to 5992 | 471 to 1 | 471/476 (98 %) | 5 diff (99.0 %id) | |||
DA863259 | placenta | .a | 729 to 1361 | 2 to 635 | capped | 634/634 (100 %) | 1 diff (99.9 %id) | ||
TI_1948086422 | .a | 787 to 1552 | 141 to 908 | 764/1330 (57 %) | 21 diff (98.5 %id) | ||||
TI_1948086423 | .a | 1848 to 2420 | 709 to 135 | 575/1370 (41 %) | 23 diff (98.4 %id) | ||||
TI_1948086597 | .a | 787 to 1549 | 142 to 912 | 769/1354 (56 %) | 19 diff (98.6 %id) | ||||
TI_1948086598 | .a | 1789 to 2420 | 765 to 130 | 636/1389 (45 %) | 14 diff (99.0 %id) | ||||
TI_1948086769 | .a | 787 to 1552 | 136 to 907 | 772/1326 (58 %) | 23 diff (98.3 %id) | ||||
TI_1948086770 | .a | 1790 to 2420 | 764 to 129 | 636/1419 (44 %) | 21 diff (98.6 %id) | ||||
TI_1948237398 | .b | 454 to 1168 | 129 to 855 | 727/1352 (53 %) | 6 diff (99.6 %id) | ||||
TI_1948237399 | .d-u | 76 to 308 | 125 to 358 | 234/251 (93 %) | 6 diff (97.7 %id) | ||||
TI_1948237400 | .b | 928 to 1210 | 408 to 126 | 283/310 (91 %) | 0 diff (100 %id) | ||||
TI_1948237401 | .b | 503 to 1210 | 832 to 125 | 708/1302 (54 %) | 0 diff (100 %id) | ||||
TI_1948237625 | .b | 662 to 1210 | 1161 to 607 | Submitted on the opposite strand | 555/1254 (44 %) | 0 diff (100 %id) | |||
TI_1948237843 | .d-u | 76 to 321 | 124 to 369 | 246/262 (93 %) | 5 diff (98.1 %id) | ||||
TI_1948238080 | .b | 454 to 1196 | 130 to 880 | 751/1317 (57 %) | 6 diff (99.6 %id) | ||||
TI_1948238081 | .d-u | 76 to 324 | 128 to 376 | 249/266 (93 %) | 5 diff (98.2 %id) | ||||
TI_1948238083 | .b | 454 to 1210 | 885 to 124 | 762/1367 (55 %) | 0 diff (100 %id) | ||||
T36264 | thyroid gland | .a | 5782 to 5987 | 206 to 1 | Submitted on the opposite strand | 206/206 (100 %) | 0 diff (100 %id) | ||
DR000925 | fetal brain | .a | 749 to 1497 | 1 to 749 | 749/749 (100 %) | 5 diff (99.4 %id) | |||
DB164414 | thymus | .a | 676 to 1254 | 2 to 581 | capped | 580/580 (100 %) | 3 diff (99.5 %id) | ||
TI_153988904 | .a | 5479 to 5987 | 601 to 92 | AAA | Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) | 510/511 (99 %) | 3 diff (99.5 %id) | ||
TI_159708438 | .a | 1 to 825 | 875 to 55 | tiling clone, | 821/1131 (72 %) | 0 diff (100 %id) | |||
DB214577 | trachea | .a | 678 to 1162 | 2 to 485 | capped | 484/484 (100 %) | 1 diff (99.8 %id) | ||
DB224186 | trachea | .a | 729 to 1315 | 2 to 588 | capped | 587/587 (100 %) | 2 diff (99.7 %id) | ||
DB240395 | trachea | .a | 725 to 1306 | 2 to 584 | capped | 583/583 (100 %) | 3 diff (99.5 %id) | ||
BP372436 | umbilical cord | .b | 546 to 1111 | 1 to 567 | 567/567 (100 %) | 3 diff (99.5 %id) | |||
BQ184597 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .c | 311 to 684 | 379 to 1 | fully sequenced, | 379/379 (100 %) | 3 diff (99.3 %id) | ||
BQ186569 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .c | 1 to 662 | 5 to 666 | tiling clone, fully sequenced, | 666/666 (100 %) | 3 diff (99.6 %id) | ||
CA748632 | Alveolar Macrophage, lung | .b | 763 to 1390 | 646 to 19 | tiling clone, AAA | Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) | 628/628 (100 %) | 0 diff (100 %id) | |
DB277866 | uterus | .a | 683 to 1087 | 2 to 406 | capped | 405/405 (100 %) | 1 diff (99.8 %id) | ||
DB278828 | uterus | .a | 678 to 1204 | 2 to 528 | capped | 527/527 (100 %) | 1 diff (99.9 %id) | ||
DB281488 | uterus | .j-u | 1 to 549 | 2 to 548 | K39G E40K N41P P42T H43L ... | capped | 547/547 (100 %) | 2 diff (99.7 %id) | |
DB352517 | uterus | .j-u | 3267 to 3829 | 563 to 1 | 563/563 (100 %) | 0 diff (100 %id) | |||
DB287875 | uterus | .a | 715 to 1284 | 2 to 571 | capped | 570/570 (100 %) | 0 diff (100 %id) | ||
DB288019 | uterus | .a | 661 to 1227 | 2 to 568 | capped | 567/567 (100 %) | 1 diff (99.9 %id) | ||
DB289924 | uterus | .a | 678 to 1270 | 2 to 594 | capped | 593/593 (100 %) | 0 diff (100 %id) | ||
DB292124 | uterus | .a | 661 to 1210 | 2 to 552 | capped | 551/551 (100 %) | 1 diff (99.9 %id) | ||
DA225027 | brain | .a | 3387 to 4002 | 1 to 626 | capped | This clone was ignored | 626/1019 (61 %) | 19 diff (98.2 %id) | |
DB305164 | brain | .a | 3387 to 4002 | 1 to 626 | This clone was ignored | 626/1019 (61 %) | 19 diff (98.2 %id) | ||
AV716977 | .a | 1686 to 2363 | 1 to 688 | Suspected internal deletion, this clone was ignored | 688/988 (69 %) | 15 diff (98.5 %id) | |||
BP321478 | placenta | .a | 1686 to 2363 | 1 to 688 | Suspected internal deletion, this clone was ignored | 688/988 (69 %) | 15 diff (98.5 %id) | ||
TI_1948086256 | .a | 4043 to 4935 | 1 to 900 | tiling clone, | This clone was ignored | 900/901 (99 %) | 20 diff (97.8 %id) | ||
TI_1948086257 | .a | 4043 to 4935 | 1 to 900 | tiling clone, | This clone was ignored | 900/901 (99 %) | 20 diff (97.8 %id) | ||
BU145898 | dorsal root ganglia | .a | 3681 to 4412 | 33 to 767 | 735/879 (83 %) | 17 diff (98.1 %id) | |||
BQ720497 | sympathetic trunk | .a | 3535 to 4453 | 1 to 923 | 923/924 (99 %) | 16 diff (98.3 %id) | |||
BQ723410 | sympathetic trunk | .a | 3498 to 4411 | 42 to 954 | 913/956 (95 %) | 19 diff (98.1 %id) | |||
CX872309 | embryonic stem | .a | 3501 to 4291 | 1 to 791 | tiling clone, | 791/791 (100 %) | 0 diff (100 %id) | ||
CB984961 | Pooled-Glandular | .a | 3701 to 4279 | 1 to 586 | 586/987 (59 %) | 15 diff (98.5 %id) | |||
CB996608 | placenta, pre-eclamptic placenta | .a | 676 to 1158 | 25 to 513 | 489/1171 (41 %) | 16 diff (98.7 %id) | |||
CB996608 | placenta, pre-eclamptic placenta | .a | 676 to 1158 | 25 to 513 | 489/1171 (41 %) | 16 diff (98.7 %id) | |||
TI_44349224 | .g | 5 to 705 | 90 to 793 | T13Q V14C P15Q G16V A17P ... | 704/922 (76 %) | 20 diff (97.9 %id) | |||
TI_44342838 | .a | 673 to 1350 | 77 to 755 | 679/756 (89 %) | 17 diff (97.8 %id) | ||||
TI_44345490 | .a | 673 to 1368 | 94 to 791 | 698/792 (88 %) | 17 diff (97.9 %id) | ||||
TI_59389296 | .b | 427 to 1255 | 103 to 927 | 825/825 (100 %) | 28 diff (96.7 %id) | ||||
TI_59391271 | .d-u | 49 to 772 | 102 to 825 | 724/724 (100 %) | 0 diff (100 %id) | ||||
BP277979 | .a | 726 to 1309 | 1 to 583 | 583/583 (100 %) | 3 diff (99.5 %id) | ||||
BY996493 | .a | 2925 to 3596 | 20 to 691 | 672/691 (97 %) | 6 diff (99.2 %id) | ||||
BY996936 | .a | 3494 to 4168 | 10 to 684 | 675/684 (98 %) | 6 diff (99.2 %id) | ||||
DA671270 | .a | 2492 to 3080 | 2 to 593 | capped | 592/592 (100 %) | 6 diff (99.0 %id) | |||
DA671469 | .a | 3871 to 4442 | 2 to 573 | capped | 572/572 (100 %) | 1 diff (99.9 %id) | |||
DA672669 | .a | 689 to 1285 | 2 to 598 | capped | 597/597 (100 %) | 3 diff (99.5 %id) | |||
NM_017839.4 | .a | 606 to 5998 | 1 to 5393 | exact | RefSeq, | 5393/5395 (99 %) | 5 diff (100.0 %id) | ||
NM_032330.1 | .d-u | 2 to 1011 | 1 to 1010 | exact | RefSeq, AAA | Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) | 1010/1010 (100 %) | 1 diff (100.0 %id) | |
AU132727 | .a | 2482 to 3230 | 2 to 746 | capped | 745/787 (94 %) | 11 diff (98.7 %id) | |||
AU154202 | .a | 3984 to 4506 | 523 to 1 | 523/523 (100 %) | 1 diff (99.9 %id) | ||||
DB374236 | placenta | .a | 5520 to 5992 | 471 to 1 | 471/476 (98 %) | 5 diff (99.0 %id) | |||
DA863259 | placenta | .a | 729 to 1361 | 2 to 635 | capped | 634/634 (100 %) | 1 diff (99.9 %id) | ||
TI_1948086422 | .a | 787 to 1552 | 141 to 908 | 764/1330 (57 %) | 21 diff (98.5 %id) | ||||
TI_1948086423 | .a | 1848 to 2420 | 709 to 135 | 575/1370 (41 %) | 23 diff (98.4 %id) | ||||
TI_1948086597 | .a | 787 to 1549 | 142 to 912 | 769/1354 (56 %) | 19 diff (98.6 %id) | ||||
TI_1948086598 | .a | 1789 to 2420 | 765 to 130 | 636/1389 (45 %) | 14 diff (99.0 %id) | ||||
TI_1948086769 | .a | 787 to 1552 | 136 to 907 | 772/1326 (58 %) | 23 diff (98.3 %id) | ||||
TI_1948086770 | .a | 1790 to 2420 | 764 to 129 | 636/1419 (44 %) | 21 diff (98.6 %id) | ||||
TI_1948237398 | .b | 454 to 1168 | 129 to 855 | 727/1352 (53 %) | 6 diff (99.6 %id) | ||||
TI_1948237399 | .d-u | 76 to 308 | 125 to 358 | 234/251 (93 %) | 6 diff (97.7 %id) | ||||
TI_1948237400 | .b | 928 to 1210 | 408 to 126 | 283/310 (91 %) | 0 diff (100 %id) | ||||
TI_1948237401 | .b | 503 to 1210 | 832 to 125 | 708/1302 (54 %) | 0 diff (100 %id) | ||||
TI_1948237625 | .b | 662 to 1210 | 1161 to 607 | Submitted on the opposite strand | 555/1254 (44 %) | 0 diff (100 %id) | |||
TI_1948237843 | .d-u | 76 to 321 | 124 to 369 | 246/262 (93 %) | 5 diff (98.1 %id) | ||||
TI_1948238080 | .b | 454 to 1196 | 130 to 880 | 751/1317 (57 %) | 6 diff (99.6 %id) | ||||
TI_1948238081 | .d-u | 76 to 324 | 128 to 376 | 249/266 (93 %) | 5 diff (98.2 %id) | ||||
TI_1948238083 | .b | 454 to 1210 | 885 to 124 | 762/1367 (55 %) | 0 diff (100 %id) | ||||
T36264 | thyroid gland | .a | 5782 to 5987 | 206 to 1 | Submitted on the opposite strand | 206/206 (100 %) | 0 diff (100 %id) | ||
DR000925 | fetal brain | .a | 749 to 1497 | 1 to 749 | 749/749 (100 %) | 5 diff (99.4 %id) | |||
DB164414 | thymus | .a | 676 to 1254 | 2 to 581 | capped | 580/580 (100 %) | 3 diff (99.5 %id) | ||
TI_153988904 | .a | 5479 to 5987 | 601 to 92 | AAA | Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) | 510/511 (99 %) | 3 diff (99.5 %id) | ||
TI_159708438 | .a | 1 to 825 | 875 to 55 | tiling clone, | 821/1131 (72 %) | 0 diff (100 %id) | |||
DB214577 | trachea | .a | 678 to 1162 | 2 to 485 | capped | 484/484 (100 %) | 1 diff (99.8 %id) | ||
DB224186 | trachea | .a | 729 to 1315 | 2 to 588 | capped | 587/587 (100 %) | 2 diff (99.7 %id) | ||
DB240395 | trachea | .a | 725 to 1306 | 2 to 584 | capped | 583/583 (100 %) | 3 diff (99.5 %id) | ||
BP372436 | umbilical cord | .b | 546 to 1111 | 1 to 567 | 567/567 (100 %) | 3 diff (99.5 %id) | |||
BQ184597 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .c | 311 to 684 | 379 to 1 | fully sequenced, | 379/379 (100 %) | 3 diff (99.3 %id) | ||
BQ184597 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .c | 311 to 684 | 379 to 1 | fully sequenced, | 379/379 (100 %) | 3 diff (99.3 %id) | ||
BQ186569 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .c | 1 to 662 | 5 to 666 | tiling clone, fully sequenced, | 666/666 (100 %) | 3 diff (99.6 %id) | ||
BQ186569 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .c | 1 to 662 | 5 to 666 | tiling clone, fully sequenced, | 666/666 (100 %) | 3 diff (99.6 %id) | ||
CA748632 | Alveolar Macrophage, lung | .b | 763 to 1390 | 646 to 19 | tiling clone, AAA | Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) | 628/628 (100 %) | 0 diff (100 %id) | |
CA748632 | Alveolar Macrophage, lung | .b | 763 to 1390 | 646 to 19 | tiling clone, AAA | Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) | 628/628 (100 %) | 0 diff (100 %id) | |
DB277866 | uterus | .a | 683 to 1087 | 2 to 406 | capped | 405/405 (100 %) | 1 diff (99.8 %id) | ||
DB278828 | uterus | .a | 678 to 1204 | 2 to 528 | capped | 527/527 (100 %) | 1 diff (99.9 %id) | ||
DB281488 | uterus | .j-u | 1 to 549 | 2 to 548 | K39G E40K N41P P42T H43L ... | capped | 547/547 (100 %) | 2 diff (99.7 %id) | |
DB352517 | uterus | .j-u | 3267 to 3829 | 563 to 1 | 563/563 (100 %) | 0 diff (100 %id) | |||
DB287875 | uterus | .a | 715 to 1284 | 2 to 571 | capped | 570/570 (100 %) | 0 diff (100 %id) | ||
DB288019 | uterus | .a | 661 to 1227 | 2 to 568 | capped | 567/567 (100 %) | 1 diff (99.9 %id) | ||
DB289924 | uterus | .a | 678 to 1270 | 2 to 594 | capped | 593/593 (100 %) | 0 diff (100 %id) | ||
DB292124 | uterus | .a | 661 to 1210 | 2 to 552 | capped | 551/551 (100 %) | 1 diff (99.9 %id) |